详情页 - 昆明医科大学第一附属医院知识库

资源类型：

文章类型：

作者：

Shao, Zonghong[1] ; Liu, Hui[2] ; Jiang, Hao[3] ; Tong, Hongyan[4] ; Xiang, Ruixiang[5] ; Yang, Linhua[6] ; Zhao, Hongguo[7] ; Ouyang, Jian[8] ; Bai, Hai[9] ; Sun, Hui[10] ; Hou, Li[11] ; Jiang, Ming[12,13] ; Yun, Zeng[14]

; Liu, Zhuogang[15] ; Liang, Aibin[16] ; Xie, Yinghua[17] ; Yu, Kang[18] ; Zhai, Zhimin[19] ; Liu, Li[20] ;

机构： [1]Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China [2]Tianjin Med Univ, Gen Hosp, Dept Hematol, Tianjin, Peoples R China [3]Peking Univ, Inst Hematol, Peoples Hosp, Beijing, Peoples R China [4]Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Hangzhou, Zhejiang, Peoples R China [5]Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China [6]Shanxi Med Univ, Hosp 2, Taiyuan, Shanxi, Peoples R China [7]Qingdao Univ, Affiliated Hosp, Dept Hematol, Qingdao, Peoples R China [8]Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China [9]Lanzhou Gen Hosp, Lanzhou Mil Area, Lanzhou, Gansu, Peoples R China [10]Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China [11]Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China [12]Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Peoples R China [13]Xinjiang Med Univ, Teaching Hosp 1, Urumqi, Peoples R China [14]Kunming Med Univ, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China [15]China Med Univ, Shengjing Hosp, Shenyang, Liaoning, Peoples R China [16]Tongti Hosp, Shanghai, Peoples R China [17]Fifth Peoples Hosp Shanghai, Blood Dis Res Ctr, Shanghai, Peoples R China [18]Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China [19]Anhui Med Univ, Affiliated Hosp 2, Hefei, Anhui, Peoples R China [20]Fourth Med Univ, Tangdu Hosp, Xian, Shaanxi, Peoples R China

出处：

DOI：

ISSN：

语种：

WOS：

中科院(CAS)分区：

出版当年[2019]版：

大类 | 1 区

医学

小类 | 1 区血液学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区血液学

JCR分区：

出版当年[2018]版：

Q1 HEMATOLOGY

最新[2023]版：

Q1 HEMATOLOGY

第一作者：

第一作者机构： [1]Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

FINAL Results of an Phase, Multicenter, Randomied, Controlled OPEN LEVEL Trial: Decitabine Therapy in Patients with Myelodysplastic Syndromes

文献详情